Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wellness BioSciences Rx is a private Houston-based health and wellness company focused on commercializing hemp-derived cannabidiol products and related delivery formats. The company launched in the U.S. in 2019 and markets medical-grade wellness consumables, including CBD softgels, oils, balm, sleep formulations, and a metered-dose inhaler format referenced in FDA correspondence. Its positioning has centered on bridging traditional healthcare and holistic wellness through physician-affiliated and independent distributor channels. Publicly available information suggests it is a small, privately held company rather than a traditional drug-development biotech with a disclosed clinical pipeline. The business appears to be oriented toward commercialization of cannabinoid wellness products rather than regulated prescription therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wellness BioSciences Rx.